Inventory Summary of IXICO plc

IXICO plc's latest annual inventory in 2023 was 1.00 USD , down 0.0% from previous year.
IXICO plc's latest quarterly inventory in 2024 Q1 was 1.00 GBP , down 0.0% from previous quarter.
IXICO plc reported annual inventory of 1.00 USD in 2022, down -50.0% from previous year.
IXICO plc reported annual inventory of 2.00 USD in 2021, down 0.0% from previous year.
IXICO plc reported quarterly inventory of 1.00 USD for 2024 Q2, down 0.0% from previous quarter.
IXICO plc reported quarterly inventory of 1.00 USD for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of IXICO plc (2023 - 1993)

Historical Annual Inventory of IXICO plc (2023 - 1993)

Year	Inventory	Inventory Growth
2023	1.00 USD	0.0%
2022	1.00 USD	-50.0%
2021	2.00 USD	0.0%
2020	2.00 USD	100.0%
2019	-1.1 Million USD	-55086300.0%
2018	2.00 GBP	100.0%
2017	1.00 GBP	-50.0%
2016	2.00 GBP	100.0%
2015	-969.43 Thousand GBP	-96944000.0%
2014	1.00 GBP	0.0%
2013	1.00 GBP	0.0%
2012	- GBP	0.0%
2011	- GBP	0.0%
2010	- GBP	-100.0%
2009	249 Thousand GBP	-37.75%
2008	400 Thousand GBP	-41.52%
2007	684 Thousand GBP	-18.86%
2006	843 Thousand GBP	-10.98%
2005	947 Thousand GBP	169.8%
2004	351 Thousand GBP	716.28%
2003	43 Thousand GBP	0.0%
2002	- GBP	0.0%
2001	- GBP	0.0%
2000	- GBP	0.0%
1999	- GBP	-100.0%
1998	9000.00 GBP	-90.53%
1997	95 Thousand GBP	458.82%
1996	17 Thousand GBP	-50.0%
1995	34 Thousand GBP	-5.56%
1994	36 Thousand GBP	-16.28%
1993	43 Thousand GBP	0.0%

Year	Inventory	Inventory Growth
2024 Q1	1.00 GBP	0.0%
2024 Q2	1.00 USD	0.0%
2023 Q4	1.00 USD	0.0%
2023 Q1	1.00 GBP	0.0%
2023 Q3	1.00 GBP	0.0%
2023 Q2	1.00 USD	0.0%
2023 FY	1.00 USD	0.0%
2022 Q1	1.00 GBP	-50.0%
2022 Q2	1.00 GBP	0.0%
2022 Q3	- GBP	-100.0%
2022 FY	- USD	-50.0%
2022 Q4	1.00 USD	0.0%
2021 Q3	1.00 GBP	-50.0%
2021 Q1	1.00 GBP	-50.0%
2021 FY	- USD	0.0%
2021 Q4	2.00 GBP	100.0%
2021 Q2	2.00 GBP	100.0%
2020 Q4	2.00 GBP	100.0%
2020 Q1	- GBP	100.0%
2020 Q2	1.00 GBP	0.0%
2020 FY	- USD	100.0%
2020 Q3	1.00 GBP	0.0%
2019 Q2	1.00 GBP	0.0%
2019 FY	- USD	-55086300.0%
2019 Q3	- GBP	-100.0%
2019 Q1	1.00 GBP	-50.0%
2019 Q4	-1.1 Million GBP	0.0%
2018 Q2	1.00 GBP	0.0%
2018 FY	2.00 GBP	100.0%
2018 Q4	2.00 GBP	100.0%
2018 Q3	1.00 GBP	0.0%
2018 Q1	- GBP	-100.0%
2017 FY	1.00 GBP	-50.0%
2017 Q4	1.00 GBP	0.0%
2017 Q3	1.00 GBP	0.0%
2017 Q2	1.00 GBP	-50.0%
2017 Q1	2.00 GBP	100.0%
2016 Q3	1.00 GBP	-50.0%
2016 FY	2.00 GBP	100.0%
2016 Q2	2.00 GBP	100.0%
2016 Q1	1.00 GBP	100.0%
2016 Q4	1.00 GBP	0.0%
2015 Q2	1.00 GBP	0.0%
2015 FY	- GBP	-96944000.0%
2015 Q3	2.00 GBP	100.0%
2015 Q1	1.00 GBP	0.0%
2015 Q4	-969.43 Thousand GBP	-48472050.0%
2014 FY	- GBP	0.0%
2014 Q1	1.00 GBP	0.0%
2014 Q4	- GBP	0.0%
2014 Q2	2.00 GBP	100.0%
2013 FY	- GBP	0.0%
2013 Q2	- GBP	0.0%
2013 Q4	- GBP	0.0%
2012 Q4	- GBP	0.0%
2012 FY	- GBP	0.0%
2012 Q2	- GBP	0.0%
2011 FY	- GBP	0.0%
2011 Q2	- GBP	0.0%
2011 Q4	- GBP	0.0%
2010 Q2	201 Thousand GBP	0.0%
2010 FY	- GBP	-100.0%
2010 Q4	- GBP	0.0%
2009 Q4	249 Thousand GBP	0.0%
2009 Q2	281 Thousand GBP	0.0%
2009 FY	249 Thousand GBP	-37.75%
2008 Q4	400 Thousand GBP	0.0%
2008 FY	400 Thousand GBP	-41.52%
2008 Q2	615 Thousand GBP	0.0%
2007 FY	684 Thousand GBP	-18.86%
2007 Q2	862 Thousand GBP	0.0%
2006 Q4	843 Thousand GBP	0.0%
2006 Q2	722 Thousand GBP	0.0%
2006 FY	843 Thousand GBP	-10.98%
2005 Q4	947 Thousand GBP	0.0%
2005 FY	947 Thousand GBP	169.8%
2005 Q2	348 Thousand GBP	0.0%
2004 Q2	195.82 Thousand GBP	0.0%
2004 Q4	351 Thousand GBP	0.0%
2004 FY	351 Thousand GBP	716.28%
2003 Q4	43 Thousand GBP	0.0%
2003 FY	43 Thousand GBP	0.0%
2003 Q2	- GBP	0.0%
2002 Q2	- GBP	0.0%
2002 FY	- GBP	0.0%
2002 Q4	- GBP	0.0%
2001 FY	- GBP	0.0%
2000 FY	- GBP	0.0%
1999 FY	- GBP	-100.0%
1998 FY	9000.00 GBP	-90.53%
1997 FY	95 Thousand GBP	458.82%
1996 FY	17 Thousand GBP	-50.0%
1995 FY	34 Thousand GBP	-5.56%
1994 FY	36 Thousand GBP	-16.28%
1993 FY	43 Thousand GBP	0.0%

Peer Inventory Comparison of IXICO plc

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	100.0%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	99.99%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	100.0%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	100.0%
Mesoblast Limited	1.00 USD	0.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	89.4 Million USD	100.0%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	100.001%
Marizyme, Inc.	24.85 Thousand USD	99.996%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	99.994%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	0.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	100.0%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	100.0%
Neon Bloom, Inc.	7938.00 USD	99.987%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	100.0%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	99.996%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	100.0%
IMV Inc.	2.00 USD	50.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	99.992%
Curative Biotechnology, Inc.	-115.62 Thousand USD	100.001%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	99.999%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	100.0%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	100.0%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	100.0%
argenx SE	310.55 Million USD	100.0%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	99.991%
Zenith Capital Corp.	3.00 USD	66.667%
Genscript Biotech Corporation	53.33 Million USD	100.0%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	99.998%
WPD Pharmaceuticals Inc.	0.25 USD	-300.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	100.0%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	100.0%
Cotinga Pharmaceuticals Inc.	0.98 USD	-2.041%
BioStem Technologies, Inc.	658.67 Thousand USD	100.0%
ONE Bio Corp.	4.5 Million USD	100.0%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	0.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	100.005%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	111.481%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	100.0%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	100.0%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IntelGenx Technologies Corp.	71 Thousand USD	99.999%
Gelesis Holdings, Inc.	6.86 Million USD	100.0%
CSL Limited	5.96 Billion USD	100.0%
Cellectis S.A.	1.00 USD	0.0%

Global Stocks Search

IXICO plc (PHYOF)

Inventory Summary of IXICO plc

Annual Inventory Chart of IXICO plc (2023 - 1993)

Historical Annual Inventory of IXICO plc (2023 - 1993)

Peer Inventory Comparison of IXICO plc